Want to see UPB full AI Analyst Report?
Upstream Bio, Inc. (UPB) Stock Statistics & Valuation Metrics
Total Valuation
Upstream Bio, Inc. has a market cap or net worth of $176.91M. The enterprise value is $117.26M.
- Market Cap
- $176.91M
- Enterprise Value
- $117.26M
Share Statistics
Upstream Bio, Inc. has 54,771,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 54,771,040
- Owned by Insiders
- 8.62%
- Owned by Institutions
- 31.50%
Financial Efficiency
Upstream Bio, Inc.’s return on equity (ROE) is -0.42 and return on invested capital (ROIC) is -47.02%.
- Return on Equity (ROE)
- -0.42
- Return on Assets (ROA)
- -0.41
- Return on Invested Capital (ROIC)
- -47.02%
- Return on Capital Employed (ROCE)
- -0.47
- Revenue Per Employee
- 38.05K
- Profits Per Employee
- -1.91M
- Employee Count
- 75
- Asset Turnover
- 0.01
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Upstream Bio, Inc. is -1.23. Upstream Bio, Inc.’s PEG ratio is 0.04.
- PE Ratio
- -1.23
- PS Ratio
- 62.09
- PB Ratio
- 0.72
- Price to FCF
- -1.44
- Price to Operating Cash Flow
- -1.43
- PEG Ratio
- 0.04
Income Statement
In the last 12 months, Upstream Bio, Inc. had revenue of 2.85M and earned -143.44M in profits. Earnings per share was -2.66.
- Revenue
- 2.85M
- Gross Profit
- 2.85M
- Operating Income
- -160.36M
- Pretax Income
- -143.44M
- Net Income
- -143.44M
- EBITDA
- -143.25M
- Earnings Per Share (EPS)
- -2.66
Cash Flow
In the last 12 months, operating cash flow was -136.34M and capital expenditures 0, giving a free cash flow of -136.34M billion.
- Operating Cash Flow
- -136.34M
- Free Cash Flow
- -136.34M
- Free Cash Flow per Share
- -2.50
Dividends & Yields
Upstream Bio, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -69.59%
- Earnings Yield
- -80.11%
Stock Price Statistics
- Beta
- 1.34
- 52-Week Price Change
- -86.35%
- 50-Day Moving Average
- 4.56
- 200-Day Moving Average
- 8.12
- Relative Strength Index (RSI)
- 40.09
- Average Volume (3m)
- 876.26K
Important Dates
Upstream Bio, Inc. upcoming earnings date is Mar 17, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 17, 2027
- Ex-Dividend Date
- ―
Financial Position
Upstream Bio, Inc. as a current ratio of 26.15, with Debt / Equity ratio of 0.37%
- Current Ratio
- 26.15
- Quick Ratio
- 26.15
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.70
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Upstream Bio, Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Upstream Bio, Inc. EV to EBITDA ratio is -0.75, with an EV/FCF ratio of -0.86.
- EV to Sales
- 37.25
- EV to EBITDA
- -0.75
- EV to Free Cash Flow
- -0.86
- EV to Operating Cash Flow
- -0.86
Balance Sheet
Upstream Bio, Inc. has $261.31M in cash and marketable securities with $954.00K in debt, giving a net cash position of $260.35M billion.
- Cash & Marketable Securities
- $261.31M
- Total Debt
- $954.00K
- Net Cash
- $260.35M
- Net Cash Per Share
- $4.75
- Tangible Book Value Per Share
- $4.97
Margins
Gross margin is 98.45%, with operating margin of -5382.65%, and net profit margin of -4955.67%.
- Gross Margin
- 98.45%
- Operating Margin
- -5382.65%
- Pretax Margin
- -4955.67%
- Net Profit Margin
- -4955.67%
- EBITDA Margin
- -4949.27%
- EBIT Margin
- -4955.67%
Analyst Forecast
The average price target for Upstream Bio, Inc. is $22.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $22.25
- Price Target Upside
- 588.85% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- 15.98%
- EPS Growth Forecast
- -40.75%
Scores
- Smart Score
- 5
- AI Score
- 46
